FDA Approves First Oral Contraceptive Pill

Context

Efforts to develop reliable contraception in the United States built on decades of advocacy amid legal restrictions and social taboos. Margaret Sanger, who had opened the nation's first birth-control clinic in 1916, sought a simple, effective method that women could control themselves. She collaborated with researchers and secured backing from philanthropist Katharine McCormick to advance pharmaceutical options beyond barrier methods or less dependable techniques then available.

What Happened

In the early 1950s, biochemist Gregory Pincus at the Worcester Foundation for Experimental Biology and gynecologist John Rock at Harvard Medical School investigated synthetic hormones to suppress ovulation. Their work produced a compound later manufactured by G.D. Searle & Company as Enovid. The drug received FDA clearance in 1957 solely for treating menstrual disorders, with a label noting it prevented ovulation. Searle filed a supplemental application in late 1959 specifically seeking approval for contraceptive use, supported by extensive clinical data from trials that had begun in 1954.

Aftermath

The May 9, 1960, approval cleared Enovid-10 for marketing as an oral contraceptive. Distribution followed quickly, with physicians prescribing it to married women under prevailing state laws. Initial uptake grew steadily as word spread, though the product carried requirements for medical supervision and carried known side effects that prompted ongoing monitoring.

Legacy

The pill's introduction provided women a reversible, daily method of fertility regulation that reshaped personal and societal expectations around family planning. It contributed to broader shifts in women's education, employment, and legal rights, including later Supreme Court decisions expanding access to contraception. The event also highlighted evolving pharmaceutical regulation and sparked enduring discussions on reproductive health policy worldwide.